120 related articles for article (PubMed ID: 17050250)
21. Human umbilical vein endothelial cells increase ex vivo expansion of human CD34(+) PBPC through IL-6 secretion.
Li N; Eljaafari A; Bensoussan D; Wang Y; Latger-Cannard V; Serrurier B; Boura C; Kennel A; Stoltz J; Feugier P
Cytotherapy; 2006; 8(4):335-42. PubMed ID: 16923609
[TBL] [Abstract][Full Text] [Related]
22. Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE.
Joo SY; Choi BK; Kang MJ; Jung DY; Park KS; Park JB; Choi GS; Joh J; Kwon CH; Jung GO; Lee SK; Kim SJ
Transplant Proc; 2009 Jun; 41(5):1885-90. PubMed ID: 19545750
[TBL] [Abstract][Full Text] [Related]
23. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
24. Evidence of similar effects of short-term culture on the initial repopulating activity of mobilized peripheral blood transplants assessed in NOD/SCID-beta2microglobulin(null) mice and in autografted patients.
Glimm H; Schmidt M; Fischer M; Klingenberg S; Lange W; Waller CF; Eaves CJ; von Kalle C
Exp Hematol; 2005 Jan; 33(1):20-5. PubMed ID: 15661394
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo manipulation of hematopoietic stem and progenitor cells.
Kanz L; Brugger W; Scheding S
Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
[TBL] [Abstract][Full Text] [Related]
27. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
28. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
29. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
[TBL] [Abstract][Full Text] [Related]
30. [Study of ex vivo expansion of mouse hematopoietic stem/progenitor cells and the use of them for hematopoiesis reconstitution].
Wang JF; Qiu LY; Harrintong J; McNiece IK
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):584-8. PubMed ID: 14720444
[TBL] [Abstract][Full Text] [Related]
31. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.
Choi BK; Joo SY; Moon C; Park KS; Kim SH; Park JB; Jung GO; Choi GS; Kwon CH; Chun JM; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2008 Oct; 40(8):2655-60. PubMed ID: 18929829
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
34. Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors.
Leone F; Cavalloni G; Gunetti M; Pignochino Y; Piacibello W; Aglietta M
Biol Blood Marrow Transplant; 2006 Jan; 12(1):68-74. PubMed ID: 16399570
[TBL] [Abstract][Full Text] [Related]
35. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells.
Tanaka H; Matsumura I; Itoh K; Hatsuyama A; Shikamura M; Satoh Y; Heike T; Nakahata T; Kanakura Y
Stem Cells; 2006 Nov; 24(11):2592-602. PubMed ID: 17071861
[TBL] [Abstract][Full Text] [Related]
36. [Purging of hemopoietic progenitor cells in autologous transplantation].
Hrubá A; Skala JP; Matĕjcková S; Fales I; Vodvárková S; Starý J; Kavan P; Kobylka P
Cas Lek Cesk; 1997 Mar; 136(5):151-3. PubMed ID: 9221189
[TBL] [Abstract][Full Text] [Related]
37. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
[TBL] [Abstract][Full Text] [Related]
38. Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells.
Chan SL; Choi M; Wnendt S; Kraus M; Teng E; Leong HF; Merchav S
Stem Cells; 2007 Feb; 25(2):529-36. PubMed ID: 17068185
[TBL] [Abstract][Full Text] [Related]
39. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
van Heeckeren WJ; Vollweiler J; Fu P; Cooper BW; Meyerson H; Lazarus HM; Simic A; Laughlin MJ; Gerson SL; Koç ON
Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019
[TBL] [Abstract][Full Text] [Related]
40. Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells.
Reichle A; Zaiss M; Rothe G; Schmitz G; Andreesen R
Bone Marrow Transplant; 2003 Aug; 32(3):299-305. PubMed ID: 12858202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
